Academia.eduAcademia.edu

Outline

APPLICATION OF MICROSPHERES IN PHARMACEUTICAL INDUSTRY

2022, Journal For Basic Sciences

https://doi.org/10.37896/JBSV22.12/1609

Abstract

Microspheres are small, round particles commonly made from biodegradable and biocompatible polymers having the scale starting from 1 to 1000μm and incorporating tablets and different bioactive inside their core. They provide numerous benefits which includes covering and shielding the encapsulated tablets from the tough surroundings of the gastrointestinal tract, sustained and controlled drug release, progressed stability, and bioavailability, site-particular focused on of the energetic healing moieties, etc. The tablets encapsulated withinside the microspheres may be focused both through their localization to precise sites of the body (for, e.g., in lungs), to a collection of cells (for, e.g., in cancer cells), or to an intracellular region (for, e.g., withinside the lysosomes). Plumbagin-loaded albumin microspheres had been additionally organized so that you can growth its healing ability and decrease the toxicity. The organized microspheres had been investigated for his or her antitumor and antifertility activities and it exhibited useful antitumor and antifertility activities in assessment to niosomes as a manage group. Microsphere (MS), which can be emulsion cells or stable particles dispersed in a non-stop segment, had been applied in numerous industries consisting of foods, cosmetics and prescription drugs etc. Emulsions are dispersed multiphase structures which include or greater nearly at the same time insoluble liquids, with the dispersed section present withinside the form of droplets in a non-stop segment. Microsphere has specific packages in pharmaceutical industry, Drug transport system, specific microspheres application & Novel software of microsphere.

References (19)

  1. Bhalerao S.S., Lalla J.K., Rane M.S., "Study of processing parameters influencing the properties of diltiazem hydrochloride", J. Microencap. 2001;18: Page no.-299-307.
  2. Bhalerao S.S., Lalla J.K., Rane M.S., "A study of electrokinetic and stability property of suspension of diltiazem hydrochloride microcapsule", Indian Drugs 2001;38: Page no.-464-467.
  3. Chowdary K.P., Ramesh K.V., "Studies on microencapsulation of diltiazem", J. Pharm. Sci. 1993;55: Page no.-52-54.
  4. Reddy M.N., Shriwaikar A.A. Rosin, "a polymer for microencapsulation of diltiazem hydrochloride for sustained release by emulsion-solvent evaporation technique", Indian J. Pharm. Sci. 2000;62: Page no.-308-310.
  5. Saravanan M., Dhanraj M.D., Sridhar S.K., Ramachandran S., Sam S.K., Rao S.G., "Preparation, characterization and in vitro release kinetics of ibuprofen polystyrene microspheres", Indian J. Pharm. Sci. 2004;66: Page no.-287-292.
  6. Pandey V.P., Manavalan R., Sundarrajan T., Ganesh K.S., 'Formulation and release characteristics of sustained release diltiazem hydrochloride tablets", Indian J. Pharm. Sci. 2003; 65: Page no.-44-48.
  7. Ishikawa T., Watanabe Y., Takayama K., Endo H., Matsumoto M., "Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water- soluble drug from tablets prepared using macrogol and HPMC", Int. J. Pharm. 2000;202: Page no.- 173-178.
  8. Higuchi T., "Mechanism of sustained-action medication -theoretical analysis of rate of release of solid drugs dispersed in solid matrices", J. Pharm. Sci. 1963;52: Page no.-1145-1149.
  9. Wagner J.G., "Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules", J. Pharm. Sci. 1969;58: Page no.-1253-1257.
  10. S. Freiberg and X. X. Zhu, "International Journal of Pharmaceutics", Volume 282, Issues 1-2, 10 September 2004, Page no.-1-18.
  11. M. A. Bayomi, S. A. Al-Suwayeh, A. M. El-Helw and A. F. Mesnad, Pharmaceutica Acta Helvetiae, Volume 73, Issue 4, December 1998, Page no.-187-192.
  12. Jin-Chul Kim, Dae Ho Kim, Min Chul Kwon, Hae Gon Chung, Seung-Jun Lee, Jong-Duk Kim, Hyeon Yong Lee, "Journal of Dispersion Science and Technology", Volume 27, Issue 2, April 2006, Page no.-165-169.
  13. Amita Bagal, Ravi Dahiya, Vance Tsai, Peter A. Adamson, "Archives of Facial Plastic Surgery", Jul/Aug 2007, Vol 9, No. 4, Page no.-275-280.
  14. Kumaresh S. Soppimath, Anandrao R. Kulkarni, Walter E. Rudzinski, Tejraj M. Aminabhavi, Drug Metabolism Reviews, Volume 33, Issue 2, April 2001, Page no.-149-160.
  15. T. Hekmatara, G. Regdon, P. Sipos, I. Er?s and K. Pintye-Hódi, "Journal of Thermal Analysis and Calorimetry", Volume 86, No.-2, November 2006, Page no.-287-290.
  16. M.N. Reddy and A .A. Shirwalkar, "Indian Journal of Pharmaceutical Sciences", April 2000, Volume 62, Issue 4, Page no.-308-310.
  17. Reza Arshadya, "Journal of Controlled Release", Volume 14, Issue 2, October 1990, Page no.- 111-131.
  18. Costas Kaparissides, Sofia Alexandridou, Katerina Kotti and Sotira Chaitidou, "A Zojono journal of Nanotechnology Online, Recent Advances in Novel Drug Delivery Systems", July, 2005, Page no.-121-131.
  19. Lidia Elfstrand , Ann-Charlotte Eliasson, Monica Jönsson , Mats Reslow, Marie Wahlgren, Starch-Stärke, Jun 2006, Volume 58, Issue 8, Page no.-381-390.